OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations
Korina Karagianni, Spyros Pettas, Georgia Christoforidou, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 465-465
Open Access | Times Cited: 15

Showing 15 citing articles:

Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases
Emmanuel Broni, Andrew Striegel, Carolyn N. Ashley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6795-6795
Open Access | Times Cited: 14

Using Zebrafish Models to Study Epitranscriptomic Regulation of CNS Functions
Jianzhong Jiang, Yun‐Qian Zhang, Jiyi Wang, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 1
Closed Access

In silico detection of dysregulated genes and molecular pathways in Alzheimer’s disease as basis for food restoring approach
Ilaria Petrignani, Alessandra Pasquo, Roberto Bei, et al.
PeerJ (2025) Vol. 13, pp. e19100-e19100
Open Access

Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular disease
Victoria Stopa, Dimitra Dafou, Korina Karagianni, et al.
Vascular Pharmacology (2025) Vol. 159, pp. 107496-107496
Closed Access

RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis
Korina Karagianni, Dimitra Dafou, Konstantinos Xanthopoulos, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3

Changes in ADAR RNA editing patterns in CMV and ZIKV congenital infections
Benjamin Wales-McGrath, Heather Mercer, Helen Piontkivska
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases
Korina Karagianni, Alessia Bibi, Alisia Madè, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 35, Iss. 1, pp. 102085-102085
Open Access | Times Cited: 5

RNA-Binding Proteins as Epigenetic Regulators of Brain Functions and Their Involvement in Neurodegeneration
Carlo Maria Di Liegro, Gabriella Schiera, Giuseppe Schirò, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14622-14622
Open Access | Times Cited: 7

The coevolution between APOBEC3 and retrotransposons in primates
Giorgia Modenini, Paolo Abondio, Alessio Boattini
Mobile DNA (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 6

The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases
Qingxia Gan, Yugang Ding, Maoyao Peng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 873-873
Open Access | Times Cited: 3

Identification of atlastin genetic modifiers in a model of hereditary spastic paraplegia in Drosophila
Noemí Candia, Andrés Ibacache, Ignacio Medina-Yáñez, et al.
Human Genetics (2023) Vol. 142, Iss. 8, pp. 1303-1315
Closed Access | Times Cited: 3

RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis
Athanasios Beopoulos, Manuel Géa, Alessio Fasano, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2

RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)
Dimitra Dafou, Ειrini Kanata, Spyros Pettas, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3582-3582
Open Access | Times Cited: 4

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies
Muhammad Abu Talha Safdar Hashmi, Hooriya Fatima, Sadia Ahmad, et al.
Ibrain (2024) Vol. 10, Iss. 4, pp. 395-426
Open Access

Page 1

Scroll to top